These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5715431)

  • 1. Chemotherapy regimens used in retreatment of pulmonary tuberculosis: combination of ethambutol, thioamides and capreomycin or rifampycin.
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    Bull Int Union Tuberc; 1968 Dec; 41():186-7. PubMed ID: 5715431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined treatment with capreomycin, ethambutol and rifampizin in chronic open pulmonary tuberculosis].
    Virchow C; Flemming J
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):40-6. PubMed ID: 5824389
    [No Abstract]   [Full Text] [Related]  

  • 4. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rabukhin AE; Gol'dshteĭn VD; Khodakevich LIa
    Probl Tuberk; 1974; (7):14-8. PubMed ID: 4409887
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 10. [New aspects of chemotherapy of tuberculosis].
    Khomenko AG
    Probl Tuberk; 1980 Jul; (7):14-9. PubMed ID: 7413630
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent-term therapeutic effects of short-course chemotherapy in rural outpatients with smear positive tuberculosis].
    Zhang YD
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Feb; 9(1):6-8, 61. PubMed ID: 3743281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV; Gavrilenko VS; Tarasova EF; Sokolova GV; Tregubov IuG
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined use of capreomycin and ethambutol in the re-treatment of pulmonary tuberculosis].
    Donomae I
    Saishin Igaku; 1968 Nov; 23(11):2393-9. PubMed ID: 5715168
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early results of treatment of chronic pulmonary tuberculosis with rifampicin and ethambutol adminstered intermittently once or twice a week preceded by a 3-month continuous administration].
    Kost A; Moskwa Z
    Gruzlica; 1975 Aug; 43(8):719-26. PubMed ID: 1158177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Capreomycin and ethambutol].
    Wilson TM
    Gruzlica; 1968 Oct; 36(10):1053-7. PubMed ID: 5710088
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interactions of reserve antitubercular agents in combined administration].
    Korotaev GA; Kozulitsyna TM
    Probl Tuberk; 1978 Sep; (9):56-60. PubMed ID: 704600
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.